Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control
NCT ID: NCT02937896
Last Updated: 2016-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2015-01-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients
NCT06570187
Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries
NCT07056582
Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit
NCT05903963
Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy
NCT06181682
Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries
NCT05872087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketorolac
30mg ketorolac administrated intravenous and 4 puffs nasal Normal Saline.
Ketorolac
30mg intravenous Ketorolac.
Normal Saline
4 puffs nasal Normal Saline.
Desmopressin
40 microgram nasal desmopressin administrated and 1cc Normal Saline intravenous
Desmopressin
40 micrograms Nasal Desmopressin.
Normal Saline
1cc intravenous Normal Saline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Desmopressin
40 micrograms Nasal Desmopressin.
Ketorolac
30mg intravenous Ketorolac.
Normal Saline
1cc intravenous Normal Saline.
Normal Saline
4 puffs nasal Normal Saline.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnant patients
* use of analgesic within 4 hours before intervention
16 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kambiz Nasiri
Emergency Medicine Resident
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
688
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.